WO2003075869A1 - Procedes de traitement capillaire - Google Patents

Procedes de traitement capillaire Download PDF

Info

Publication number
WO2003075869A1
WO2003075869A1 PCT/US2003/007087 US0307087W WO03075869A1 WO 2003075869 A1 WO2003075869 A1 WO 2003075869A1 US 0307087 W US0307087 W US 0307087W WO 03075869 A1 WO03075869 A1 WO 03075869A1
Authority
WO
WIPO (PCT)
Prior art keywords
hair
bioactive glass
weight
composition
particles
Prior art date
Application number
PCT/US2003/007087
Other languages
English (en)
Inventor
Guy Latorre
Kevin Mckenzie
Original Assignee
Usbiomaterials Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usbiomaterials Corporation filed Critical Usbiomaterials Corporation
Priority to AU2003228295A priority Critical patent/AU2003228295A1/en
Priority to US10/506,522 priority patent/US20050214235A1/en
Priority to DE10392362T priority patent/DE10392362T5/de
Publication of WO2003075869A1 publication Critical patent/WO2003075869A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/004—Preparations used to protect coloured hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/651—The particulate/core comprising inorganic material

Definitions

  • the present Invention relates to compositions and methods of use
  • the softer keratins are components of the external layers of skin, wool, hair and feathers, while the harder types predominate In nails, claws and hoofs.
  • a cross section taken through a terminal hair shaft reveals two distinct components, the cuticle and the cortex.
  • the cuticle is the outermost surface of the hair shaft and is composed of a very hard keratinous substance, while the inner bulk of the hair is composed of a more fibrous keratin and is known as the cortex.
  • keratin is an Insoluble proteinaceous complex composed of high molecular weight polypeptide chains. These polypeptide chains are composed of a series of amino acids joined head-to-tail by peptide linkages, the actual properties of the polypeptide being determined by the number, type and order of amino acids In the chain. Typically, keratins are insoluble In organic solvents but do absorb and hold water.
  • the cuticle of hair generally consists of flattened platelets of amorphous keratin, wrapped around the hair shaft In several layers, each layer overlapping the adjacent one progressing from the root of the hair to its tip. The condition of the cuticle Is responsible for the outward appearance of the hair and dictates the attributes of feel and shine.
  • the cuticle platelets In virgin hair, the cuticle platelets lay flat against each other and are firmly adhered to the cortex, giving rise to a very smooth feeling surface with a high degree of shine, if the hair is subjected to environmental or physical damage, the cuticle platelets can become chipped, raised or even detached completely, exposing the cortex underneath. This gives rise to hair in poor condition, which feels rough to the touch and is dull in appearance.
  • U.S. Patent No.3,864,475 relates to a method of treating human hair to enhance softness and improve the general appearance by intimately contacting the hair with an aqueous treating composition containing water and a catalytlcaily effective amount of a catalyst.
  • the catalyst may be prepared by admixing a water soluble alkali metal silicate with an aqueous medium containing a dissolved substance which is source of calcium ion and a dissolved substance which is a source of magnesium ion to produce a finely divided or colloidal suspension of the reaction product.
  • the colloidal suspension Is then agitated sufficiently in the presence of a micelle-forming surfactant to form catalyst-containing micellee ⁇ .
  • U.S. Patent No.3,958,581 relates to the treatment of degraded hair by use of cosmetic compositions containing at least one cationic polymer and at least one non-toxic salt of a divalent metal.
  • U.S. Patent No.5,635,168 teaches compositions and methods for treating hair using an aqueous composition of at least 1 % by weight total of one or more polyvalent metal compounds; a sulfur-containing material that has an average molecular weight of 10,000 or less that can form dlsulfide bonds involving the keratin of the hair, and whose sulfur content is at least about 1 % by weight; and optionally, an acid.
  • Methods for treating hair include treating hair with bioactive glass compositions which comprises particulate bioactive glass or bioactive glass extracts.
  • the bioactive glass compositions may further comprise a ca ⁇ ier and/or optional components useful In hair treatment formulations.
  • the method comprises applying an effective hair-enhancing amount of a bioactive glass composition to the hair for a sufficient amount of time such that the hair is coated with the bioactive glass composition.
  • the coating comprises a film comprising silicon, calcium, and/or phosphorus ions which may interact with the hair. Additionally, sodium or other Ions released from the bioactive glass composition may be present.
  • the hair after application of the bioactive glass composition Is smooth and silky with increased body.
  • the method comprises applying an effective hair-enhancing amount of bioactive glass extract(s) (solutions with ions and substantially no particles) to the hair for a sufficient amount of time such that the hair is coated with a precipitated film or coating comprising silicon, phosphorous and calcium. Additionally, sodium or other ions released from the bioactive glass extracts may be present.
  • the method comprises applying a shampoo or conditioner to hair, the shampoo or conditioner comprising an effective hair-enhancing amount of a bioactive glass composition which may comprise non-interlinked particles of bioactive glass or bioactive glass extract.
  • Figure 1 is a scanning electron microscopy (SEM) micrograph at a magnification of 500x showing film formation on hair after treatment with the bioactive glass and tris buffer formulation of Group #1 described in the Example.
  • Figure 2 is a scanning electron microscopy (SEM) micrograph at a magnification of 4500x showing film formation on hair after treatment with the bioactive glass and tris buffer formulation of Group #1 described in the Example.
  • SEM scanning electron microscopy
  • Figure 3 is an Energy Dispersive Spectrometer (EDS) spectrum showing the presence of silicon, calcium and phosphorus on hair after treatment with the bioactive glass and tris buffer formulation of Group #1 described in the Example.
  • EDS Energy Dispersive Spectrometer
  • Rgure 4 is a Fourier Transform Infrared Spectroscopy (FTIR) spectrum which Illustrates that the calcium and phosphorus in the film are in the form of crystalline hydroxyapatite.
  • FTIR Fourier Transform Infrared Spectroscopy
  • Figure 5 is a scanning electron microscopy (SEM) micrograph at a magnification of 500x showing film formation on hair after treatment with the bioactive glass extract formulation of Group #2 described In the Example.
  • Rgure 6 is a scanning electron microscopy (SEM) micrograph at a magnification of 4500x showing film formation on hair after treatment with the bioactive glass extract formulation of Group #2 described in the Example.
  • Figure 7 is an Energy Dispersive Spectrometer (EDS) spectrum showing the presence of silicon, calcium and phosphorus on hair after treatment with the bioactive glass extract formulation of Group #2 described in the Example.
  • EDS Energy Dispersive Spectrometer
  • Rgure 8 is a scanning electron microscopy (SEM) micrograph at a magnification of 500x showing lack of film formation on hair after treatment with the tris buffer control for Groups #1 and #2 described In the Example.
  • Figure 9 is a scanning electron microscopy (SEM) micrograph at a magnification of 4500x showing lack of film formation on hair after treatment with the tris buffer control for Groups #1 and #2 described in the Example.
  • Figure 10 is an Energy Dispersive Spectrometer (EDS) spectrum showing the absence of silicon, calcium and phosphorus on hair after treatment with the tris buffer control for Groups #1 and #2 described in the Example.
  • EDS Energy Dispersive Spectrometer
  • Rgure 11 is a scanning election microscopy (SEM) micrograph at a magnification of 500x showing film formation on hair after treatment with the bioactive glass, tris buffer and shampoo formulation of Group #3 described In the Example.
  • SEM scanning election microscopy
  • Rgure 12 is a scanning electron microscopy (SEM) micrograph at a magnification of 4500x showing film formation on hair after treatment with the bioactive glass, tris buffer and shampoo formulation of Group #3 described in the Example.
  • Figure 13 is an Energy Dispersive Spectrometer (EDS) spectrum showing the presence of silicon, calcium and phosphorus on hair after treatment with the bioactive glass, tris buffer and shampoo formulation of Group #3 described in the Example.
  • EDS Energy Dispersive Spectrometer
  • Figure 14 is a scanning electron microscopy (SEM) micrograph at a magnification of 500x showing film formation on hair after treatment with the bioactive glass extract and shampoo formulation of Group #4 described In the Example.
  • Figure 15 is a scanning electron microscopy (SEM) micrograph at a magnification of 4500x showing film formation on hair after treatment with the bioactive glass extract and shampoo formulation of Group #4 described in the Example.
  • Figure 16 is an Energy Dispersive Spectrometer (EDS) spectrum showing the presence of silicon, calcium and phosphorus on hair after treatment with the bioactive glass extract and shampoo formulation of Group #4 described in the Example.
  • EDS Energy Dispersive Spectrometer
  • Figure 17 is a scanning electron microscopy (SEM) micrograph at a magnification of SOOx showing lack of film formation on hair after treatment with the tris buffer and shampoo control for Groups #3 and #4 described in the Example.
  • SEM scanning electron microscopy
  • Rgure 18 is a scanning electron microscopy (SEM) micrograph at a magnification of 4500x showing lack of film formation on hair after treatment with the tris buffer and shampoo control for Groups #3 and #4 described in the Example.
  • Figure 19 is an Energy Dispersive Spectrometer (EDS) spectrum showing the absence of silicon, calcium and phosphorus on hair after treatment with the tris buffer control for Groups #3 and #4 described In the Example.
  • EDS Energy Dispersive Spectrometer
  • the hair treatment methods of the present invention involve application to hair of bioactive glass compositions comprising particulate bioactive glass or bioactive glass extract.
  • the treatment provides a film on the hair which results in hair with greater body, smoothness and silki ⁇ ess.
  • the hair treated may be hair from or on any mammal such as hair on dogs or cats, but preferably will be human hair.
  • biologically active glass mean an inorganic glass material having an oxide of silicon as its major component and which is capable of bonding with growing tissue when reacted with physiological fluids.
  • Bioactive glasses are well known to those skilled in the art, and are disclosed, for example, in An Introduction to Bioceramlcs, L. Hench and J. Wilson, etds. World Scientific, New Jersey (1993).
  • the bioactive glass of the present Invention typically will contain about 40 to about 86 % by weight of silicon dioxide (SiO 2 ), about 0 to about 35 % by weight of sodium oxide (Na 2 O), about 4 to about 46 % by weight calcium oxide (CaO), and about 1 to about 15 % by weight phosphorus oxide (P ⁇ O-J).
  • the oxides may be present as solid solutions or mixed oxides, or as mixture of oxides.
  • One or more of CaF 2 , B 2 O 3 , Al-jOg, MgO and f ⁇ O may be included in the composition in addition to silicon, sodium, calcium and phosphorus oxides.
  • the B 2 O 3 may be present in an amount of about 0 to 10 % by weight
  • the K 2 O may be present In an amount of about 0 to about 8 % by weight
  • the Al 2 0 3 may be present in an amount of about 0 to about 4 % by weight
  • the MgO may be present in an amount of about 0 to about 5 % by weight
  • the CaF 2 may be present in an amount of about 0 to about 30 % by weight.
  • Bioglass® 45S5 which has a composition including about 45 % by weight silicon dioxide (SIO 2 ), about 24.5 % by weight sodium oxide (Na 2 0), about 6 % phosphorus oxide (P 2 O 5 ), and about 24.5 % by weight calcium oxide (CaO).
  • the bioactive glass of the bioactive glass compositions may be used in either particulate or extract form.
  • particulate, non-interlinked bioactive glass Is selected.
  • This glass is in the form of small, discrete particles, rather than a fused matrix of particles or a mesh or fabric (woven or non-woven) of glass fibers. Under some conditions the discrete particles of the bioactive glass may tend to cling together because of electrostatic or other forces but these particles are still considered to be non-Interlinked.
  • the average particle size is about 90 microns or less.
  • the average particle size Is less than about 20 microns, or, more preferably, less than about 5 microns, and even more preferably less than about 1 micron.
  • Particle size is measured by SEM or other optical microscopy techniques, or by laser light scattering techniques (i.e., using a Coulter counter).
  • the bioactive glass may be prepared In any way known to those of skill In the art.
  • the bioactive glass may be provided as melt- derived glass, sol-gel derived glass or sintered glass particles.
  • the sintered particles may be In sol-gel derived, or pre-reacted melt derived form.
  • Melt derived glass typically is prepared by mixing grains of oxides or carbonates, melting and homogenizing the mixtures at high temperatures, generally about 1250 to about 1400°C. The molten glass can be fritted and milled to produce a small particulate material.
  • Sol-gel derived glass is typically prepared by synthesizing an Inorganic network by mixing metal alkoxides In solution, followed by hydrolysis, gelation, and low temperature (less than about 1000°C) firing to produce glass.
  • the bioactive glass may also be used in extract form.
  • An extract of bioactive glass is a solution of ions derived from bioactive glass.
  • the solution of bioactive glass comprises ions and substantially no particles.
  • solution is included solutions, suspensions and dispersions of bioactive glass.
  • an extract of bioactive glass may be formed from a solution made by reacting bioactive glass particles In an appropriate solvent such as water or tris buffer for an appropriate amount of time to create a solution of bioactive glass. The solution may then be filtered and used as a bioactive glass extract which is substantially particle free.
  • the ratio of Ions in solution will depend on the bioactive glass starting material and the amount of time it reacts In solution. The ion ratios may be controlled by use of various bioactive glass materials or by varying the reaction time.
  • the bioactive glass or bioactive glass extract typically will be applied directly to hair in conjunction with a carrier.
  • the carrier may be aqueous or nonaqueous.
  • the carrier preferably will be aqueous, alcohol based or other organic carriers or combinations thereof.
  • cosmetic compositions can be provided in the form of aerosol sprays, foams or gels. While the ratio of bioactive glass to carrier is not critical, the bioactive glass composition will typically be about 0.5 to about 20 % of the total bioactive glass carrier formulation, including any optional components. Preferably, the amount of bioactive glass in the total composition will be about 2 to about 10 %.
  • the bioactive glass or bioactive glass extract composition generally will be provided in an effective hair-enhancing amount.
  • An effective, hair- enhancing amount is an amount capable of providing a thin film or coating on the hair of bbactive glass or ions from the bioactive glass which are believed to Interact with the keratin In the hair to provide beneficial qualities to the hair.
  • these ions will be calcium, silicon and/or phosphorus.
  • Other ions which may be present, depending on the composition of the bioactive glass, include sodium, magnesium, potassium, zinc, copper or silver, among others.
  • the thin film typically will be about 0.1 to about 5 microns thick.
  • the thin film formed on tiie hair will be about 0.3 to about 2 microns thick.
  • bioactive glass or bioactive glass extract composition causes a layer of hydroxyapatite or other calcium phosphate crystals to form on the hair surface.
  • the ions from the bioactive glass are believed to penetrate layers of the hair to form hydroxyapatite crystals within the layers of the hair and may penetrate layers of the hair to form chemical bonds bridging the layers of the cuticle.
  • the bioactive glass or bioactive glass extract composition generally will be applied to the hair for a time sufficient to treat the hair. Typically, tills time will allow a coating or film to form or precipitate onto the hair. The ions in the coating may then interact with the hair to enhance the hair. In general, tiie time needed is about the time typically used to shampoo the hair, although a longer time may be used.
  • the methods for treating hair of the invention may Involve use of a hair treatment formulation which is removed or washed off after use, or a hair treatment formulation such as a gel, mousse, cream, lotion, air Infused styling foam or spray formulation which is left on after application.
  • the bioactive glass or bioactive glass extract is applied to hair in a carrier in a rinse type of formulation.
  • the bioactive glass or bioactive glass extract composition is applied to hair in a shampoo or conditioner formulation.
  • Such formulations are well known In the art.
  • Application of the bioactive glass composition to the hair is believed to build body in the hair, and make hair smooth and silky.
  • the methods of the invention may be used to prevent or repair damage to the hair caused by mechanical, chemical or environmental factors.
  • the hair treatment of the present invention may also impart a beneficial antj-microbial or anti-fungal activity for the hair, scalp or skin.
  • Such treatment may be useful against microbes such as B. subtilis, S. aureus, P. aureginosa, C. aiblcan ⁇ , A. nig ⁇ r, E. coil, A. alternate, and C. xerosls.
  • the hair treatment methods of the invention may also be used to improve curt retention, color receptivity, color stability, color retention, shine, and/or strength.
  • the hair treatment fomnuiations of the present Invention may further comprise one or more optional components known for use in shampoo or conditioning compositions, provided that the optional components are physically and chemically compatible with the bioactive glass composition described herein* or do not otherwise unduly impair product stability, aesthetics or performance. Concentrations of such optional components typically range from about 0.001% to about 10% by weight of the total composition.
  • Optional components include a ⁇ tl-sta ⁇ c agents, dyes, organic solvents or diluents, peariescent aids, foam boosters, surfactants or cosurfactants (nonionic, cationic, zwitterionlc), pediculocides, pH adjusting agents, perfumes, preservatives, proteins, skin active agents, suspending agents, styling polymers, sunscreens, thickeners, vitamins, blotin, collagen, amino acids, protein hydrolyzates, herbals, penetration enhancers, permeation/binding agents, and viscosity adjusting agents.
  • This list of optional components is not meant to be exclusive, and other optional . components can be used.
  • the hair treatment methods of the invention preferably use compositions maintained at a pH appropriate for the particular application.
  • the pH will be below about 10; preferably, the pH will be between about 3 and about 9.
  • compositions were prepared and tested to evaluate the use of bioactive glass partlculatos, extracts and shampoo solutions.
  • the bioactive glass used was BlogiassTM 45S5 powder with a particle size less than about 20 ⁇ m. These compositions are detailed In Table I.
  • Two control formulations were also prepared and tested. The first control formulation corresponded with Groups #1 and #2 and contained only tris buffer. The second control formulation corresponded with Groups #3 and #4 and contained tris buffer and shampoo. These control formulations were viewed by SEM/EDS, with the results shown in Figures 8-10 and 17-19.
  • Group #2 - bioactive glass extract 1. 90.0 grams of bioactive glass particulate with a particle size less than about 20 ⁇ m and 510.0 mi of tris buffer solution were allowed to vortex In a 1000ml beaker for two hours at room temperature.
  • the SEM/EDS and FTIR results for group #1 are presented in Figures 1 , 2, 3 and 4.
  • the SEM micrographs indicate that a substantial film has been formed on the hair surface after reaction In tris buffer and bioactive glass particulate. Magnification to 4500x indicates that this film is non-uniform in coverage of the hair surface.
  • the EDS analysis indicates the presence of Si, Ca, Na and P, which is not seen in the Group 1 and 2 control in Figure 10.
  • the presence of SI may indicate that some bioactive glass particulate may be present or that a soluble form of silicon has been incorporated on the hair surface.
  • the SEM EDS results for group #2 are presented in Figures 5, 6 and 7.
  • the SEM micrographs indicate that a film has been formed on the hair surface after reaction in tris buffer and bbactive glass extract solution. Magnification to 4500x as shown in Figure 6 indicates that this film is non- uniform in coverage of tiie hair surface. The film appears to be more dense on the edges of the cuticle scales of the hair structure.
  • the EDS analysis of Rgure 7 Indicates the presence of SI, Ca, Na and P, which is not seen In the Group 1 and 2 control in Rgure 10.
  • the presence of SI may indicate that soluble form of silicon has been incorporated on tiie hair surface, as there are no bioactive glass particles in this filtered solution.
  • the presence of Al is an artifact due to the aluminum mount used for SEM/EDS analysis.
  • Group #3 - tris buffer and bioactive glass particulate with shampoo [0062]
  • the SEM EDS results for group #3 are presented In Figures 11, 12 and 13.
  • the SEM micrographs indicate that a transparent film has been formed on the hair surface after reaction in the tris buffer, bioactive glass particulate and shampoo mixture.
  • Magnification to 4500x In Figure 12 indicates that this film is uniform In coverage of the hair surface.
  • the linear cracks seen in the micrographs were formed during the SEM analysis. These cracks could be seen growing as the image was focused in the process of acquiring the micrograph.
  • the EDS analysis indicates the presence of Si, Ca, Na and P, which is not seen in the Group 3 and 4 control in Figure 19.
  • the SEM EDS results for group #4 are presented in Figures 14, 15 and 16.
  • the SEM micrographs indicate that a transparent film has been formed on the hair surfece after reaction in the tris buffer, bioactive glass extract and shampoo mixture. Magnification to 4500x in Figure 15 indicates that this film is uniform in coverage of the hair surface.
  • the linear cracks seen in the micrographs were formed during the SEM analysis. These cracks could be seen growing as the Image was focused in the process of acquiring the micrograph. The extent of the cracking was less for this group than seen for the group #3 sample.
  • the EDS analysis indicates tiie presence of Si, Ca, Na and P, which Is not seen in the Group 3 and 4 control in Figure 19.
  • the data presented Indicates that both bioactive glass suspensions and extracts in tris buffer (groups #1 and #2) have the ability to deliver calcium, phosphorus and silicon to the hair surfece.
  • the SEM/EDS analysis indicates that a non-continuous film is being famed on the surfece of the hair and is thicker on the edges of the cuticle scales of the hair structure.
  • the FTIR analysis from group #1 shown in Figure 4 indicates that the calcium and phosphorus are in the form of crystalline hydroxyapatite.
  • the data also indicates that the mo ⁇ hology of tills film changes with the addition of a commercial shampoo.
  • the resulting film Is continuous and transparent in nature, as seen with Groups #3 and #4.
  • the EDS analysis indicates that this film contains calcium, phosphorus and silicon and is thicker in the extract solution Group #4 than the suspension group #3 mixed with shampoo.
  • the data shows that bioactive glass Interacts with human hair.

Abstract

L'invention concerne des procédés de traitement capillaire qui font intervenir des formulations contenant des compositions de verre bioactif et un support approprié. Ces procédés consistent à appliquer les formulations de traitement capillaire sur les cheveux. Ces formulations à base de compositions de verre bioactif peuvent contenir des particules non conjuguées de verre bioactif ou de l'extrait de verre bioactif, un support et/ou d'autres composants facultatifs utilisés dans les formulations de traitement capillaire.
PCT/US2003/007087 2002-03-07 2003-03-07 Procedes de traitement capillaire WO2003075869A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2003228295A AU2003228295A1 (en) 2002-03-07 2003-03-07 Methods of treating hair
US10/506,522 US20050214235A1 (en) 2002-03-07 2003-03-07 Methods of treating hair
DE10392362T DE10392362T5 (de) 2002-03-07 2003-03-07 Verfahren zur Behandlung von Haaren

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36235902P 2002-03-07 2002-03-07
US60/362,359 2002-03-07

Publications (1)

Publication Number Publication Date
WO2003075869A1 true WO2003075869A1 (fr) 2003-09-18

Family

ID=27805163

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/007087 WO2003075869A1 (fr) 2002-03-07 2003-03-07 Procedes de traitement capillaire

Country Status (3)

Country Link
AU (1) AU2003228295A1 (fr)
DE (1) DE10392362T5 (fr)
WO (1) WO2003075869A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876281A1 (fr) * 2004-10-07 2006-04-14 Oreal Procede de traitement cosmetique des fibres keratiniques, et utilisation cosmetique d'un modulateur de transglutaminase
WO2006040445A1 (fr) * 2004-10-07 2006-04-20 L'oreal Procédé de traitement cosmétique des fibres kératiniques, et utilisation cosmétique d'un modulateur de transglutaminase.
WO2009010367A2 (fr) * 2007-07-13 2009-01-22 Henkel Ag & Co. Kgaa Agents contenant un principe actif anti-irritant
US7754194B2 (en) 2005-04-06 2010-07-13 L'oréal Hair relaxer compositions utilizing bioactive glass
US8691300B2 (en) 2009-08-28 2014-04-08 Mary Kay Inc. Skin care formulations
US10130673B2 (en) 2006-01-19 2018-11-20 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534892A (en) * 1982-07-27 1985-08-13 Kao Corporation Foaming liquid detergent composition having a stably dispersed water-insoluble fine powder
WO2000009641A1 (fr) * 1998-08-17 2000-02-24 The Procter & Gamble Company Detergents multifonctionnels

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534892A (en) * 1982-07-27 1985-08-13 Kao Corporation Foaming liquid detergent composition having a stably dispersed water-insoluble fine powder
WO2000009641A1 (fr) * 1998-08-17 2000-02-24 The Procter & Gamble Company Detergents multifonctionnels

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006040445A1 (fr) * 2004-10-07 2006-04-20 L'oreal Procédé de traitement cosmétique des fibres kératiniques, et utilisation cosmétique d'un modulateur de transglutaminase.
FR2876281A1 (fr) * 2004-10-07 2006-04-14 Oreal Procede de traitement cosmetique des fibres keratiniques, et utilisation cosmetique d'un modulateur de transglutaminase
US7754194B2 (en) 2005-04-06 2010-07-13 L'oréal Hair relaxer compositions utilizing bioactive glass
US10918591B2 (en) 2006-01-19 2021-02-16 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US10130673B2 (en) 2006-01-19 2018-11-20 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US10668124B2 (en) 2006-01-19 2020-06-02 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US10675323B2 (en) 2006-01-19 2020-06-09 Mary Kay Inc. Topical compositions comprising acai berry extract
WO2009010367A3 (fr) * 2007-07-13 2011-06-16 Henkel Ag & Co. Kgaa Agents contenant un principe actif anti-irritant
WO2009010367A2 (fr) * 2007-07-13 2009-01-22 Henkel Ag & Co. Kgaa Agents contenant un principe actif anti-irritant
US8691300B2 (en) 2009-08-28 2014-04-08 Mary Kay Inc. Skin care formulations
US8895082B2 (en) 2009-08-28 2014-11-25 Mary Kay Inc. Skin care formulations
US9833642B2 (en) 2009-08-28 2017-12-05 Mary Kay Inc. Skin care formulations
US10434340B2 (en) 2009-08-28 2019-10-08 Mary Kay Inc. Skin care formulations
US11123578B2 (en) 2009-08-28 2021-09-21 Mary Kay Inc. Skin care formulations
US11596813B2 (en) 2009-08-28 2023-03-07 Mary Kay Inc. Skin care formulations
US11679284B2 (en) 2009-08-28 2023-06-20 Mary Kay Inc. Skin care formulations

Also Published As

Publication number Publication date
DE10392362T5 (de) 2005-04-14
AU2003228295A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
EP1143919B1 (fr) Procede de traitement des ongles
EP3691751B1 (fr) Composition de coloration capillaire à deux composants polymères
CA2106717C (fr) Composition claire pour le traitement sans rincage des cheveux et methode
EP1490423B1 (fr) Copolymeres de proteine et de silane et/ou de proteine et de siloxane, leur preparation et leur utilisation
CA2946215A1 (fr) Produits de consommation
JPH02202811A (ja) 毛髪処理組成物
KR20110068876A (ko) 모발을 선택적으로 처리하기 위한 방법
EP1121090A2 (fr) Compositions de traitement capillaire obtenues par recombinaison
EP1121946B1 (fr) Cheveux artificiels et procédé pour leur fabrication
EP1675572B1 (fr) Particules de pyrithione metallique enrobees pour l'elimination de micro-organismes
US20220016017A1 (en) Color coatings with downstream features
JP2021529832A (ja) 多成分組成物
WO2003075869A1 (fr) Procedes de traitement capillaire
CA2696435A1 (fr) Composition pour communiquer des agents de benefice a des substrats cationiques et procedes pour son utilisation
WO2003045336A1 (fr) Emulsifiant et procede d'elaboration correspondant
MY133831A (en) High alkaline hair compositions for increased fullness and body
US20050214235A1 (en) Methods of treating hair
KR20060035343A (ko) 폴리에틸렌 글리콜 유도체를 유효성분으로 함유하는 모발코팅용 조성물
KR20080058134A (ko) 모발 처리용 조성물, 모발 처리제 및 이를 이용한 모발처리방법
CN1197548C (zh) 水不溶性芳族聚合物用的水性运载体系
JP3774166B2 (ja) 毛髪処理剤及び毛髪処理方法
WO2007136286A1 (fr) Formulation contenant des domaines de liaison hydrophobes et des domaines de liaison aux glucides pour applications cosmétiques, plus spécifiquement pour le traitement de fibres de kératine telles que les cheveux
CN112618408A (zh) 一种复合蛋白发质修护组合物及其应用
US6444196B1 (en) Hair treatment composition and method
JP4646098B2 (ja) 化粧品基材

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
WWE Wipo information: entry into national phase

Ref document number: 10506522

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP